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ABSTRACT
￿
Apoproteins have important physiologic functions in lipoprotein metabolism . Sev-
eral apoproteins are produced in the intestine including ApoA-I, ApoA-IV, and ApoB . Each
appears to participate in intestinal lipid transport . The liver also produces several apoproteins,
including ApoC-II and ApoC-III, but the data demonstrating the ability of the intestine to
produce ApoC is incomplete . Our aim was to ascertain whether ApoC-11 and ApoC-III were
present in human and rat jejunum, and if so, whether their presence was altered by fat feeding .
The technique of immunolocalization and a newly developed double antibody radioimmu-
noassay for rat ApoC-111 3 were used . ApoC-111 3 was found in the supranuclear regions of
enterocytes along the entire lengths of villi in the jejuna of 12-h-fasted rats . 1 hour after the
gastric ingestion of corn oil, ApoC-1113 was found primarily in between cells and in the lamina
propria . Similar results were obtained in human jejunal biopsies with ApoC-II and ApoC-III .
ApoC-1113 was also detected by radioimmunoassay in enterocytes isolated from jejuna of
neonatal and adult rats . Thus, ApoC-II and ApoC-III are clearly present in the intestine as well
as in the liver . In addition, because their localization is altered after fat feeding, they are also
likely to be produced in the enterocyte .
The production of apoproteins by enterocytes and the impor-
tant roles of apoproteins in intestinal fat absorption are well
established . ApoA-I and ApoB have been localized in entero-
cytes immunologically and their intercellular localization
changes during fat absorption (1-3) . Simultaneously, there are
alterations in levels of these apoproteins in intestinal cells (3,
4) . In addition, ApoA-I, ApoA-IV, and ApoB have been found
in chylomicrons isolated from intestinal lymph (5-8) . In tracer
experiments, lymph chylomicrons also incorporate substantial
amounts of labeled amino acids into ApoA-I, ApoA-IV, and
ApoB (9, 10) . It seems clear, therefore, that these apoproteins
somehow participate in intestinal lipid transport .
By contrast, ApoE, although it is found in small intestinal
crypt cells, does not alter its intercellular localization in the
same way as do the other apoproteins during fat absorption
(3) . Also, chylomicrons contain only small amounts of ApoE
(5, 8), and in tracer experiments, ApoE isolated from lymph
chylomicrons contains very little, if any, labeled amino acid (9,
10) . Thus, ApoE, which probably has an important role in
hepatic lipid transport (3, 11, 12), has an unknown or perhaps
no important role in the transport of intestinal lipids .
ApoC-II and ApoC-III, which are important as modulators
of the activity of lipoprotein lipase (13, 14), are found in both
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intestinal lymph chylomicrons (9, 10) and in very low density
lipoprotein (VLDL) isolated from hepatic perfusions (15-17) .
However, whileVLDL-ApoC incorporates labeled amino acids
during hepatic perfusion (10, 18), chylomicron-ApoC isolated
from intestinal lymph contains relatively little label (9, 10) . To
assess the role of the intestine in the production of ApoC, we
have adapted immunologic techniques for the localization (19,
20) and the quantitation (3) of proteins in cells, and applied
these techniques to studies ofApoC inhuman and rat intestine .
MATERIALS AND METHODS
Human intestinal biopsies were obtained from fasting normal volunteers with a
biopsy tube (Quinton Instruments, Seattle, Wash.), or at surgery using protocols
and consent procedures approved by the Washington University Human Studies
Committee . Tissue from overnight-fasted Sprague-Dawley or Wistar rats were
obtained under ether anesthesia. For indirect immunotluorescence localization
studies (3), tissues were rinsed in ice-cold 0.16 M NaCl, quickly blotted, frozen
in liquid nitrogen-cooled Freon at -158 °C and stored in screw-cap vials at
-70°C until used . 4-lam-thick frozen sections were cut from tissue blocks in a
microtome cryostat . Fixing and staining ofsections was carried out as previously
described using rabbit anti-rat apoprotein or rabbit anti-human apoprotein
antisera (see below) at 1 :200-1 :400 dilutions freshly prepared in phosphate-
buffered saline, and goat anti-rabbit IgG (tluorescein-conjugated IgG fraction,
Meloy Laboratories Inc ., Springfield, Va .) . Controls for the immunofuorescence
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follows: (a) with buffer alone, i .e ., without either rabbit anti-rat apoprotein
antiserum or foresceinated goat anti-rabbit IgG conjugate, (b) with conjugate
alone, (c) with nonimmune rabbit serum (NIRS) at the same dilution as immune
sera and conjugate, (d) with immune sera directed against irrelevant antigens
and conjugate, and (e) with specific anti-rat or human apoprotein antisera
absorbed with the appropriate apoprotein antigens.
For immunoperoxidase localizations, tissues were fixed in picric acid-2%
formaldehyde phosphate buffer, pH 7.4 (2l), for 10 min, embedded, paraffin
sectioned (4 lam), and mounted on microscope slides. Mounted sections were
deparaffmized by two washes in xylene and three washes in isopropanol and
then incubated sequentially with nonimmune goat serum (NGS), rabbit anti-rat
(1:100-1 :200 dilutions) or anti-human apoprotein serum (1:200-1:400 dilutions),
NGS, goat anti-rabbit IgG, and goat peroxidase-antiperoxidase complex (PAP,
N. L . Cappel Laboratories Inc., Cochranville, Pa .) . The peroxidase reaction was
developed with 0.0125% diamino benzidine-tetrahydrochloride (DAB), 0.0025%
H202 (22). Slides were then stained with 4% osmium, dehydrated, and covered
with a coverslip (Permount, Fisher Scientific Co., Pittsburgh, Pa .) . Controls for
peroxidase immunolocalizations consisted of tissue sections incubated with DAB
and H202 but (a) with buffer alone, (b with PAP but in the absence of anti-
apoprotein antisera or nonimmune serum, (c) with NIRS, and (d) with anti-
apoprotein antisera whichhad been absorbed with the appropriate antigens. For
both fluorescenceand immunoperoxidase staining, adjacent sections were stained
with hematoxyline and eosin, and used in the identification of tissue structures.
Apoprotein contents were determined in homogenates of mucosal scrapings
and ofisolated intestinal cells of the rat. Mucosa was scraped by the use ofglass
slides from noneverted intestine kept chilled on a glass plate . Scraping removes
the mucosa, leaving only underlying muscularis behind. Isolated intestinal cells
were prepared by the method ofMerchant and Heller (23) using buffer B (0.137
M NaCl, 2.69 mM KCI, 8.10 mM Na 2HPO4, 1.5 mM EDTA, and 0.5 mM
dithiothreitol at pH 7.4) . Segments of intestine were distended with the buffer
and incubated at 37 oCfor 20, 40, and 60 min . The released cells were harvested
by centrifugation andwashed twice by centrifugation in 15 mM Tris, pH 7.4 . On
histologic examination of the treated intestinal segments, these incubation times
yielded cells enriched from the outer, middle, and lower villus (and crypt) areas,
respectively. Phase microscopy ofthe washed isolated cell preparations revealed
intact cells or clumps of 2 or 3 cells, with little cellular debris. Mucosal scrapings
and isolated cells were homogenized in 4 vol and 2 ml of 15 mM Tris, pH 7.4,
respectively, and then assayed for their contents of total proteins (24) and
apoproteins (25, and see below) and for their activities of sucrase (26). For the
ApoC-III,, radioimmunoassay (RIA), homogenates of mucosal scrapings were
treated with urea as follows: Mix 100-lal samples with 3001x1 of8 M urea, incubate
for 2h at 37°C, dilute sample 1:10 in buffer, and assay . In separate experiments
it was shown that the amounts of urea used did not interfere with the assay .
Specificities ofantisera were tested in double antibody immunoprecipitations
as described (3) . The monospecificities of the anti-rat ApoA-I, anti-rat ApoB,
and ApoE antisera have been previously documented . The anti-rat apoprotein
antisera bound <2% of the inappropriate apoprotein . The antisera used in the
immunolocalization studies in human tissues were the same antisera used for
RIA's of those apoproteins (27-31) . The antisera againsthuman apoproteins A-
1, A-II, B, E, C-II, and C-III were able to bind 85-95% of the appropriate 12`1_
labeled apoproteins, but<3%of other 1251-labeled apoproteins .
Because the double antibody RIA for rat ApoC-1113 has not been previously
published, the reagents and the assay procedure will be described here . ApoC-
I113 was isolated from rat high density lipoprotein (HDL) (d 1.070-1 .21, one spin
at d 1.070, two at d 1.21, each spin for 2x 10g-min) by column chromatography .
First,HDLwas lyophilized and delipidated with etherethanol (2 :3, vol/vol) then
the relatively small ApoC's were isolated from the larger apoproteins by chro-
matography on a 2.5 x 90 cm column of Sephadex G200 (0.01MTris, 8M urea,
pH 8.6). The ApoC-containing peak was then chromatographed on DEAE
cellulose (Whatman DE 52) using a 2-liter Tris-urea linear gradient (32). ApoC-
III 3 was identified by its position in the elution profile, by isoelectricfocusing (33,
34) and by amino acid analysis (performed in the laboratory of Dr . Ralph
Bradshaw, Department of Biological Chemistry, Washington University School
of Medicine, St. Louis, Mo .) . ApoC-1113 which yielded a single band and had the
appropriate amino acid composition (32), was used as immunizing antigen, as
1251-labeled tracer, and as assay standard. Anti-ApoC-ííI3 antiserawere produced
in rabbits. Anti-rabbit IgG was prepared in goats. Iodination was carried by
lactoperoxidase and H202 as described for human ApoA-11 (28) . The resulting
1251-ApoC-1113 was separated from unreacted ...I-Na by chromatography on
Sephadex G-25 . Label was stored frozen at -20'C in 0.05 M barbital, pH 8.6,
15% bovine serum albumin (fraction V, BSA, Sigma Chemical Co ., St. Louis,
Mo .) and purified before each assay by chromatography on Sephadex G50 (0.05
M barbital, pH 8.6, 0.01% Triton X-100, assay buffer) . The calculated specific
radioactivity of 1251 was ^-15 liCi/lag and iodinations were carried out every 4-6
wk . Greater than 95% ofthe label was precipitable by 10% TCA and --90% was
precipitable by excess anti-rat ApoC-1113 antisera (R-211) . The anti-ApoC-1113
antisera bound<2%ofrat 12oí-ApoC-II, 1251-ApoA-I, 1251-ApoB,and 1251-ApoE.
Thus, all ofthe antisera used in this report were monospecific for their respective
antigens.
TheRIA tubes contained 100 pl o£ antisera (final dilution 1:4,400), 100 fit of
I25í-ApoC-ííI3 (-15,000 cpm, 12 mg), 501Al of NIRS (final dilution 1 :500), 10-
200 ILI ofsamples or standards (diluted as needed in assay buffer), and sufficient
assay buffer to bring the volume to 550 Id. (All dilutions were carried out using
buffer.) After mixing of the tubes, they were incubated for 42 h at 4oC, 50 lal of
goat anti-rabbit IgG was then added (final dilution 1:220), and incubation was
continued at 4'C for another 16 h . Tubes were then centrifuged at 3,000 g for 30
min, precipitates were "washed" in ice-cold saline and then countedin a Packard
Autogamma Spectrometer (Packard Instrument Co ., Inc., Downers Grove, Ill.).
Tubesthat contained all reagents except for anti-ApoC-III, wereincluded in each
assay to test for nonspecific precipitation . The counts in these tubes, <3%added
counts, were subtracted from each assay tube to obtain net counts. Results were
calculated on a programmable calculator (Hewlett-Packard Co ., Palo Alto, Calif.)
using a program provided by the vendor which weights points to obtain a best-fit
curve using the logit B/Bo vs . dose (ng) plot .
where Bo= net counts per minute in the absence of standard or sample and B
= net counts per minute in the presence of standard or sample. In an attempt to
shorten and simplify the assay, incubation conditions were changed as follows:
Add 250 pl of sample/buffer, 100 lal of NIRS or antiserum, 100 pl of labeled
ApoC-1113 . Incubate for 2 h at 37*C and for 16 h at 5'C . Add 300 lal of 30%
polyethylene glycol (P-155 Carbowax PEG6000 Flake, Fisher Scientific Co .) 35
pl 1:7 dilution ofbovine serum (nonhemolyzed, adult from Pel-Freez Biologicals
Inc., Rogers, Ark.). Vortex, let stand 8 or 10 min, centrifuge at 2,400 rpm for 25
min . Count precipitates. These incubation conditions yielded plasma values
comparable to the ones obtained with the double antibody assays and the latter
conditions were used to obtain tissue levels of ApoC-lí13 .
RESULTS
ApoC-1113 Assay
The addition of increasing amounts of ApoC-111 3 standard
to the assay tubes resulted in the production of typical com-
petitive displacement curves (Fig . 1) . The coefficient of varia-
tion of triplicate tubes in 12 assays ranged 2-6% and averaged
4% . The mean slopes, intercepts, and r values (-!:I SD) of 12
curves run over 10 mo were -2.62 ± 0.31, 2.60 ± 0.29, and
0.995, respectively. To ascertain whether the assay detects not
only ApoC-111 3 but also the less sialylated formsof ApoC-1113,
ApoC-lllo was added to the assay . On a per unit mass basis it
produced only 5% of the displacement produced by ApoC-Ills .
VLDL, HDL, and whole plasmas produced displacement
curves which had slopes within ±1 SD of the slopes of the
standard curves, but ratApoA-1,ApoC-11, and ApoE produced
no displacement of counts even at doses of 1,000 ng, indicating
that the assaywas specific for ApoC-111 3 . LDL (d 1 .025-1 .050)
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FIGURE 1
￿
Displacement curves produced by rat ApoC-1113 standard
in rat ApoC-1113 RIA (for ApoC-1113 and ApoC-II, scale of abscissa is
nanograms of protein) . Assay tubes contained rabbit anti-rat ApoC-
1113 , NIRS rat 1251-ApoC-111 3 , and goat anti-rabbit IgG. Displacement
curves produced by rat plasma (unmarked curves, scale of abscissa
is microliter of sample) paralleled those produced by the ApoC-1113
standard . ApoC-11 produced virtually no displacement of counts .
Homogenates of mucosal scrapings and of isolated enterocytes also
produced parallel displacement curves (not shown) .
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LDL-protein [by Lowry's method, reference 24]) . Four rat
HDL (d 1.070-1 .19) and four d< 1 .070 fractions contained 9-
13% and 23-35% ApoC-1113 (percent of lipoprotein protein).
These percentages are compatible with those obtained on
column chromatographic separation of rat HDL and VLDL
+ LDL apoproteins (32, 35, 36), suggesting that the assay is
accurate . As a separate check on accuracy, increasing amounts
of ApoC-II1 3 were added to a rat plasma pool (four plasmas)
andthe plasma samples with and without the added ApoC-II13
were assayed . Recoveries of added ApoC-III3 were 95% ± 9
(n = 9). ApoC-1113 contents of 11 female and 13 male rats fed
Purina rat chow were 17 ± 4 and 18 ± 4, respectively . Delipi-
dation of the plasmas (27) had no effect on their contents of
ApoC-111 3 .
Intestinal Mucosal Contents ofApoC-1113
Homogenates of mucosal scrapings of adult rat jejunal mu-
cosal scrapings contained 55 ± 6 ng of ApoC-III 3/mg of
protein, and 28 ± 11 ng ofApoA-I/mg (Table I). Homogenates
ofjejunal and ileal mucosal scrapings of 16-h-fasted, 13-d-old
suckling rats contained 30 and25 ng of ApoC-III 3/mghomog-
enate protein, respectively . The analogous ApoA-I contents of
these homogenateswere 45 ng/mg for thejejunum and48 ng/
mg for the ileum (3).
Homogenates of isolated cells derived largely from the outer
villus of adult rats contained more ApoC-1113 than did middle
villus cells (Table 1) . Lowest ApoC-II13 levels were found in
isolated cells derived mostly from the lower villus and crypt
regions . A similar gradient from the top to the bottom of the
villus was noted for sucrase activity . (The ApoC-1113 contents
of isolated cells homogenized in 150mM Tris, pH 7.4, in the
presence of 1% Triton X-100 were not significantly different
from those homogenized in the absence of Triton X-100 .
Aliquots ofcell homogenates were centrifuged at 105,000 g for
30 min . Supernatant fractions and pellets contained 78 and
22% of the total tissue levels of ApoC-1I1 3 . Therefore, results of
whole homogenates are given.)
It was important to determine that the preparation ofisolated
cells wasnot contaminated by plasma.Threeexperiments were
performed which excluded this possibility . First, '251-labeled
ApoA-I and 1251-ApoC-111 3 were injected intravenously into
rats at a level of radioactivity such that contamination of
intestinal tissue by plasma of 0.1% would be easily detected .
TABLE I
ApoC-111 3 Contents of Rat Intestine
Mucosal scrapings on isolated villus cells were obtained as described in
Materials and Methods . The results refer to the mean ± SEM of three separate
preparations, or the mean of two experiments with individual values in
parentheses .
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FIGURE 2 Immunoperoxidase localization of ApoC -1113 in rat je-
junum . The top (A) and the bottom (8) of a villus of a 16-h-fasted
rat demonstrated the presence of ApoC-1113 in the supranuclear
(Golgi) regions of enterocytes (see arrows) . 1 h after theadministra-
tion of 1 .5 ml of corn oil by stomach tube (C and D) most of the
stain is found in between cells (top arrow in C) and in the lamina
propria beneath the enterocytes and in lacteale (see arrows) . N,
nucleus ; C, cytoplasm; and Lp, lamina propria .
No
1251 counts were found in the isolated intestinal cell prepa-
ration with either 1251-labeledapoprotein . Second, we measured
ApoA-I and ApoC-1113 levels in mucosal scrapingsand also in
the isolated cells derived from adjacent intestinal segments of
three separate rats . ApoA-I contents in three scraped mucosal
preparations which might contain plasma contaminants were
40, 26, 19 ng/mg protein and in isolated washed cells of the
same intestines were 243, 207, 251 ng/mg. Values for ApoC-
III3 in mucosalscrapings were 61, 52, 51 ng/mg protein and in
cells isolated from the entire villus were 65, 51, 54 . As can be
seen from Table I, the specific activity of cells from the outer
and middle villus is greater than that from the mucosal scrap-
ings . Finally, the presence of albumin in this cell preparation
was looked for by immunoelectrophoresis and none was de-
tected . Thus, it seems unlikely that plasma contamination
contributed significantly to the apoprotein content in the iso-
lated cell preparation .
As a further control on the specificity ofourmethods, ApoA-
Apo C-III
ng/mg
ApoA-I
protein
Sucrase
,a molglucose/
min/ml
Mucosa scrapings 55 ± 6 28 ± 11 0.44 (0 .47, 0.41)
Isolated villus
cells
Outer 94 (73, 114) 0.82 (0.79, 0.85)
Middle 68 (57,78) 0.66 (0.65, 0.67)
Lower and 46 (42, 49) 0.22 (0.25, 0.19)
crypt
Total 57 t 7 234 ± 23I and ApoC-1113 were determined in several other organs and
tissues of the rat . Because the plasma concentrations ofApoA-
I and ApoC-1113were 528pg and 19 f~g/ml, respectively, far in
excess of intestinal tissue levels, we prepared animal carcasses
free of plasma by extensively perfusing the whole animal via
the aorta with Krebs-Ringer bicarbonate buffer, and removed
the heart, gastrocnemius muscles, brain, and lung for analysis .
No ApoA-I or ApoC-1113 was detectable in homogenates (100 1o
wt/vol) of these tissues . By contrast, ApoC-1113 was found in
48-h primary cultures of rat hepatocytes at levels of 55 ng/mg
protein (Schonfeld and Patsch, unpublished observations) .
Immunolocalization ofApoC-111 3 in Rat Intestine
ApoC-1113was localized within the ratjejunal enterocytes by
the PAP procedure (Fig . 2) . Specific reaction product was
found in the supranuclear regions of enterocytes throughout
the length of the villus in tissues from 16-h-fasted rats (Fig . 2A
and B) . This region corresponds to that ofthe Golgi apparatus.
There was little or no staining of the lamina propria .
Tissues were also sampled 1 hafter theadministration of 1 .5
ml of corn by stomach tube (Fig . 2C and D) . (The animals
were awake during intubation and until just before tissue
samples were taken.) The amount of supranuclear staining for
ApoC-1113 along the whole villus decreased but staining ap-
peared between enterocytes at the tip of the villus . In addition,
the lamina propria became heavily stained, particularly in the
lacteals (see arrows) . Similar results were obtained withApoA-
I (Fig . 3A and B) and ApoB (not shown) . Indeed, after fat
feeding the amount of A-I seen between and at the base of
enterocytes was much greater than in the case of ApoC-III 3
(compare Fig . 2C with Fig . 3B). In addition, as canbe seen in
both villi shown in Fig . 3 B, the amount of ApoA-I staining in
the Golgi region was somewhat diminished when compared
with the fasted tissue (Fig . 3A) .
Stain was also deposited along the brush border and in the
region of the terminal web not only in tissues stained with
antisera, but also in tissues stained with NIRS (Fig . 3C and
D) . Therefore, staining of this region was consideredanonspe-
cific reaction . Nonspecific staining of the brush border was
also seen with the immunofluorescent technique (see Fig . 4A) .
Erythrocytes were also nonspecifically stained (Fig . 3C and
D) . Staining for ApoC-111 3 was looked for in tissue slices made
from rat stomach, colon, brain, pancreas, andmuscle. The only
positive staining found was in blood vessels . However, slices
made from rat liver demonstrated that hepatocytes stained
strongly for ApoC-1Ií 3 and weakly for ApoA-I (not shown) .
Immunolocalization of ApoC-11 and ApoC- 111 in
Human Intestine
Apo C-III in human jejunum behaved as it did in rat (Fig .
4Cand D) . (The anti-human ApoC-III antisera did not distin-
guish between the sialylated forms of ApoC-III [31] .) Specific
immunofluorescence caused by ApoC-III was present in the
supranuclear (Golgi) areas of enterocytes throughout thelength
ofthe villus in 12 to 14-h-fasted subjects. On rebiopsy after the
subjects drank 50 ml of a com oil formula, most of the ApoC-
III immunofluorecence was found in the basal portions of cells
and in the lamina propria. ApoC-II was also found in fasting
human enterocytes (Fig . 3B) and behaved similarly after corn
oil feeding (not shown) . Supranuclear fluorescence was not
seen in tissues incubated with nonimmune serum (Fig . 4A) .
FiGuat 3
￿
Immunoperoxidase localization of ApoA-I in the villi of
rat jejunum . (A) 16-h-fasted rat; (B) 1 h after 1 .5 ml of corn oil . The
stain is present primarily in the supranuclear (Golgi) regions in the
fasted state ; at 1 h, stain is found in between and at the bottoms of
cells and in the lamina propria . At 1 h the staining intensity in the
supranuclear regions appears diminished (compare A and B) . Cand
D are adjacent slides stained in the presence of NIRS . Nonspecific
staining is visible in the area of the enterocyte terminal web, brush
border, and of erythrocytes in the lamina propria . The supranuclear
regions are free of stain . N, nucleus ; C, cytoplasm, and LP, lamina
propria .
DISCUSSION
It isnowclear that severaloftheapoproteins found in lipopro-
teins of intestinal lymph are synthesized in the gut itself (1-
10) . Similarly, the liver synthesizes several of the apoproteins
found in lipoproteins of hepatic origin (il-13, 15-18) . How-
ever, the patterns of synthesis in the two organs are quantita-
tively not alike . Whereas themajor apoprotein products of the
intestine are ApoA-I and ApoA-IV, the major products ofthe
liver are ApoE, ApoC-II, and ApoC-III . Both organs produce
ApoB in abundance . These differences are interesting because
the lipid moieties transported by the two organs are similar,
but the mechanisms responsible for the organ specificities are
unknown .
The aim of this work was to ascertain whether any of the
ApoC's were present in enterocytes and whether they partici-
pated in any way in fat absorption . We investigated this
question usingsome of the immunolocalization and apoprotein
quantitation techniques we used previously forApoA-I, ApoB,
and ApoE in rat liver and intestine (3) . Immunolocalization
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￿
Immunofluorescence localization of ApoC-11 and ApoC-III in human jejunal enterocytes . Sections were obtained from
biopsies . All sections shown are from near the tips of villi . A is a section processed in the presence of NIRS . (It represents the most
intensely stained control of the five nonimmune sera used .) The nonspecific staining of the brush-border region is evident . B is a
section stained for ApoC-11 and is taken from an individual after 16 h of fasting ; Cand D are sections from the same individual
stained for ApoC-III . In this preparation the nonspecific staining of the brush-border region was much less intense than in other
biopsies . C is a 16-h-fasted sample ; D is a rebiopsy from the same individual 1 h after the oral ingestion of 50 ml of corn oil . The
corn oil induced depletion of cellular stain andthe appearance of stain in the lamina propria areobvious . c, cytoplasm ; n, nucleus ;
Ip, lamina propria .
requires that the antisera be monospecific and that appropriate
positive and negative controls be run We demonstrated that
the rat anti-ApoC-1113 antisera were indeed monospecific . Sim-
ilarly, we demonstrated the monospecificity ofthe human anti-
ApoC-II and anti-ApoC-III antisera (31) . Using these antisera,
we found that ApoC-III3 waspresent in rat intestine (and liver)
but not in other rat tissues . The determination of tissue levels
of ApoC-III required an immunoassay which was specific,
precise, and accurate . The RIA's for rat ApoC-III 3 and for
human ApoC-11 and ApoC-III fulfill these criteria . Therefore,
tissue levels could be determined with precision . The RIA's
confirmed that ApoC-II and ApoC-III were present in human
intestine and that ApoC-1113 was present in the rat intestine
(and liver, but not in other rat tissues) . Furthermore, the
intracellular localizations of the apoproteins were altered with
fat feedings. (Rat ApoC-1113 levels in intestinal cells are also
altered [Alpers, Grimme, and Schonfeld, unpublished obser-
vations]). In this respect, the behaviors ofApoC-11 and ApoC-
III resemble those of ApcIA-I and ApoB (2, 3) . These data
suggest that ApoC-II and C-III are indeed present in the
enterocyte and that these proteins are involved in fat absorp-
tion.
While we were studying intestinal apoproteins by immuno-
logic means, Wu and Windmueller reported on the intestinal
synthesis of ApoC-II and ApoC-III in rat in their elegant
perfused intestinal system (9, 10) . They demonstrated the in-
corporation of small amounts of label in the ApoC-II and
ApoC-IIh, of chylomicrons, VLDL, and HDL isolated from
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intestinal lymph . From other experiments they concluded that
the intestine contributed ^-8% of the circulating ApoC pool .
Thus, two independent lines of evidence suggest that ApoC-II
and ApoC-III may be produced in the intestine .
The roles, if any, of ApoC-II and ApoC-III in intestinal fat
transport remain to be elucidated, but the presence of chylo-
microns in the plasmas of subjects with ApoC-II deficiency
after fat feeding (37) suggests that ApoC-11 maynotbe essential
for intestinal chylomicron production .
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